TrialJournal of the American Heart Association2016

Individualized Angiotensin-Converting Enzyme (ACE)-Inhibitor Therapy in Stable Coronary Artery Disease Based on Clinical and Pharmacogenetic Determinants: The PERindopril GENEtic (PERGENE) Risk Model.

Rohit M Oemrawsingh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.